Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib plus Capecitabine in Elderly/Poor PS Metastatic Esophageal Cancer
NCT00891878Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by Cancer and Leukemia Group B. Started Aug 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00891878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891878.